A Comprehensive Map of FDA-Approved Pharmaceutical ProductsHao Zhong, Defang Ouyang|Pharmaceutics|2018Cited by 282
Near‐infrared fluorophores with absolute aggregation‐caused quenching and negligible fluorescence re‐illumination for in vivo bioimaging of nanocarriersYifan Cai, Wei Wu, Xin Ji et al.|Aggregate|2022Cited by 76
The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic reviewShuang Zhang, Jiahong Lu, Qi Zhu et al.|Phytomedicine|2020Cited by 71
Resveratrol in experimental Alzheimer’s disease models: A systematic review of preclinical studiesJiayue Chen, Jiahong Lu, Shuang Zhang et al.|Pharmacological Research|2019Cited by 64
Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitorTing Li, Jin‐Jian Lu, Zhangjian Huang et al.|Toxicology and Applied Pharmacology|2017Cited by 44